RCEL

NASDAQ open

AVITA Medical

15.84 USD
▼-0.15-0.94%
盘后 16.64 0.00%
2026-11-20
市值
$494.96M
市盈率
—
EPS
-1.18
股息率
—
52 周区间
3.22 – 18.43
成交量
185.52K
Beta
2.01
目标价
20.63
52W 低 3.2252W 高 18.43
价格走势

公司简介

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting devi...